Legal Representation
Attorney
Erich G. Rhynhart
USPTO Deadlines
Next Deadline
46 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
December 24, 2025
Extension Available
Until December 24, 2025
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 9, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 9, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 8, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 8, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 24, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 12, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 12, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 23, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 2, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 12, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 12, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 12, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 17, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 27, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 19, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products, namely, prescription drugs and biological preparations for treating chronic diseases, respiratory diseases, arthritic diseases, for ophthalmological use, and for the prevention of high blood pressure; generic prescription drugs for treating chronic diseases, respiratory diseases, arthritic diseases, for ophthalmological use, and for the prevention of high blood pressure
Classification
International Classes
005